Progress of targeted FOX family therapy in ovarian cancer.

Front Pharmacol · 2025 · PMC12310647 · PMID 40746724

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

( Hu et al., 2015 ) reported a progressive increase in FOXP1 expression across normal ovarian tissue, benign tumors, borderline tumors, and malignant OCs, while ERα expression exhibited a decreasing trend.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.